B-type Natriuretic Peptide (BNP) is the Most Specific and Useful Test
In this 61-year-old man with dyspnea on exertion, hypertension, smoking history, and basal crackles, B-type natriuretic peptide (BNP) is the most specific and helpful laboratory test for diagnosing heart failure as the cause of his dyspnea.
Clinical Reasoning
This patient's presentation—dyspnea on exertion with basal crackles in the setting of longstanding hypertension—strongly suggests heart failure as the underlying diagnosis. The key diagnostic challenge is distinguishing cardiac from non-cardiac causes of dyspnea, and BNP excels at this specific task.
Why BNP is Superior
BNP has been specifically validated for diagnosing heart failure in patients presenting with dyspnea 1. The landmark Breathing Not Properly (BNP) Multinational Study demonstrated that BNP was more accurate than clinical evaluation alone in identifying heart failure as the cause of dyspnea, with 83% diagnostic accuracy using a cut-off of 100 pg/mL 1.
The diagnostic thresholds are well-established 2, 1:
- BNP <100 pg/mL: Heart failure is effectively ruled out (high negative predictive value)
- BNP 100-500 pg/mL: Heart failure is possible; consider alternative diagnoses
- BNP >500 pg/mL: Heart failure is very likely
Why the Other Options Are Less Appropriate
C-reactive protein (CRP) is a non-specific inflammatory marker that does not help differentiate cardiac from non-cardiac dyspnea. It has no established role in diagnosing heart failure.
Creatinine Kinase (CK) is elevated in muscle injury and has no diagnostic utility for heart failure or dyspnea evaluation.
Troponin T is specific for myocardial injury/infarction, not heart failure per se. While troponin may be elevated in acute decompensated heart failure, it is not the primary diagnostic test for heart failure and would not be the most helpful test in this subacute presentation (2-day history). Troponin is most useful when acute coronary syndrome is suspected.
Guideline Support
The ACC/AHA guidelines explicitly state that "measurement of BNP or NT-proBNP is useful to support the clinical diagnosis of HF" in patients with dyspnea but uncertainty of heart failure 2. The Canadian Cardiovascular Society guidelines similarly emphasize that BNP testing is useful and complementary to clinical evaluations in diagnosing heart failure, particularly when history, physical examination, and chest radiographs are suggestive but not clearly diagnostic 1.
The ESC guidelines recommend that plasma natriuretic peptide level should be measured in all patients with acute dyspnea and suspected heart failure to help differentiate heart failure from non-cardiac causes 3.
Important Caveats
Be aware that BNP can be elevated in conditions other than heart failure 2, 1:
- Cardiac causes: Acute coronary syndrome, atrial fibrillation, LV hypertrophy, pulmonary embolism
- Non-cardiac causes: Advanced age (>75 years), renal failure, COPD, sepsis
Conversely, BNP may be falsely low in obese patients 1.
Despite these limitations, BNP remains the single most specific and useful laboratory test for establishing the diagnosis of heart failure in this clinical scenario, with superior diagnostic accuracy compared to clinical assessment alone 1.